{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T02:32:09Z","timestamp":1784169129247,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T00:00:00Z","timestamp":1566604800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.nmd.2019.07.006","type":"journal-article","created":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T19:48:33Z","timestamp":1564170513000},"page":"664-670","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Heterogeneity and shifts in distribution of muscle weakness in myasthenia gravis"],"prefix":"10.1016","volume":"29","author":[{"given":"Robert H.P.","family":"de Meel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn R.","family":"Tannemaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan J.G.M.","family":"Verschuuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.nmd.2019.07.006_bib0001","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/jaut.1995.0011","article-title":"Myasthenia gravis, a model of organ-specific autoimmune disease","volume":"8","author":"Berrih-Aknin","year":"1995","journal-title":"J Autoimmun"},{"issue":"10","key":"10.1016\/j.nmd.2019.07.006_bib0002","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2019.07.006_bib0003","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000004676","article-title":"Myasthenia Gravis Impairment Index: responsiveness, meaningful change, and relative efficiency","author":"Barnett","year":"2017","journal-title":"Neurology"},{"issue":"17","key":"10.1016\/j.nmd.2019.07.006_bib0004","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1212\/01.wnl.0000327669.75695.38","article-title":"Treatment of ocular symptoms in myasthenia gravis","volume":"71","author":"Bhanushali","year":"2008","journal-title":"Neurology"},{"issue":"1\u20132","key":"10.1016\/j.nmd.2019.07.006_bib0005","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jns.2013.06.018","article-title":"Myasthenia gravis: new therapeutic approaches based on pathophysiology","volume":"333","author":"Lewis","year":"2013","journal-title":"J Neurol Sci"},{"issue":"3","key":"10.1016\/j.nmd.2019.07.006_bib0006","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S1474-4422(18)30037-1","article-title":"Distinct representation of muscle weakness in QMG and MG-ADL","volume":"17","author":"de Meel","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2019.07.006_bib0007","article-title":"Sensitivity of MG-ADL for generalized weakness in myasthenia gravis","author":"de Meel","year":"2018","journal-title":"Eur J Neurol"},{"issue":"5","key":"10.1016\/j.nmd.2019.07.006_bib0008","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.nmd.2019.07.006_bib0009","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1136\/jnnp.73.6.766","article-title":"Difference in distribution of muscle weakness between myasthenia gravis and the Lambert\u2013Eaton Myasthenic syndrome","volume":"73","author":"Wirtz","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.nmd.2019.07.006_bib0010","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1212\/WNL.46.1.30","article-title":"Muscles of a different 'color': the unusual properties of the extraocular muscles may predispose or protect them in neurogenic and myogenic disease","volume":"46","author":"Porter","year":"1996","journal-title":"Neurology"},{"issue":"13","key":"10.1016\/j.nmd.2019.07.006_bib0011","first-page":"2817","article-title":"Extraocular fast myosin heavy chain expression in the levator palpebrae and retractor bulbi muscles","volume":"38","author":"Lucas","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.nmd.2019.07.006_bib0012","article-title":"Three hierarchies in skeletal muscle fibre classification: allotype, isotype and phenotype","author":"Hoh SH","year":"1989"},{"issue":"3","key":"10.1016\/j.nmd.2019.07.006_bib0013","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4103\/2347-8659.143664","article-title":"Current overview of myasthenia gravis and experience in China","volume":"1","author":"Guo","year":"2014","journal-title":"Neuroimmunol Neuroinflamm"},{"issue":"2","key":"10.1016\/j.nmd.2019.07.006_bib0014","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mus.20950","article-title":"Lifetime course of myasthenia gravis","volume":"37","author":"Grob","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2019.07.006_bib0015","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/archopht.1959.04220060057010","article-title":"Evaluation of ocular signs and symptoms in myasthenia gravis","volume":"62","author":"Schlezinger","year":"1959","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"10.1016\/j.nmd.2019.07.006_bib0016","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/jnnp.52.10.1121","article-title":"The natural course of myasthenia gravis: a long term follow up study","volume":"52","author":"Oosterhuis","year":"1989","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"10.1016\/j.nmd.2019.07.006_bib0017","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1007\/s00415-018-9056-8","article-title":"Generalization after ocular onset in myasthenia gravis: a case series in Germany","volume":"265","author":"Li","year":"2018","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.nmd.2019.07.006_bib0018","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/WNO.0000000000000276","article-title":"Relationship between age, gender, and race in patients presenting with myasthenia gravis with only ocular manifestations","volume":"36","author":"Peragallo","year":"2016","journal-title":"J Neuroophthalmol"},{"issue":"1","key":"10.1016\/j.nmd.2019.07.006_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1258\/0022215011906740","article-title":"Bulbar presentations of myasthenia gravis in the elderly patient","volume":"115","author":"Sharp","year":"2001","journal-title":"J Laryngol Otol"},{"issue":"4","key":"10.1016\/j.nmd.2019.07.006_bib0020","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10072-009-0095-x","article-title":"Late onset generalized myasthenia gravis presenting with facial weakness and bulbar signs without extraocular muscle involvement","volume":"30","author":"Cucurachi","year":"2009","journal-title":"Neurol Sci"},{"issue":"6","key":"10.1016\/j.nmd.2019.07.006_bib0021","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1212\/WNL.42.6.1153","article-title":"Chronic limb-girdle myasthenia gravis","volume":"42","author":"Oh","year":"1992","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.nmd.2019.07.006_bib0022","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.nmd.2017.06.009","article-title":"Exome sequencing identifies targets in the treatment-resistant ophthalmoplegic subphenotype of myasthenia gravis","volume":"27","author":"Nel","year":"2017","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1016\/j.nmd.2019.07.006_bib0023","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/nyas.13471","article-title":"A unique subphenotype of myasthenia gravis","volume":"1412","author":"Heckmann","year":"2018","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"10.1016\/j.nmd.2019.07.006_bib0024","doi-asserted-by":"crossref","first-page":"e36603","DOI":"10.1371\/journal.pone.0036603","article-title":"Late onset myasthenia gravis is associated with HLA DRB1\u00d715:01 in the Norwegian population","volume":"7","author":"Maniaol","year":"2012","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.nmd.2019.07.006_bib0025","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ana.410210309","article-title":"Heterogeneity in myasthenia gravis: HLA phenotypes and autoantibody responses in ocular and generalized types","volume":"21","author":"Kida","year":"1987","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2019.07.006_bib0026","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.clim.2016.05.003","article-title":"Genetic heterogeneity within the HLA region in three distinct clinical subgroups of myasthenia gravis","volume":"166-167","author":"Saruhan-Direskeneli","year":"2016","journal-title":"Clin Immunol"},{"issue":"7","key":"10.1016\/j.nmd.2019.07.006_bib0027","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.nmd.2017.04.002","article-title":"HLA and age of onset in myasthenia gravis","volume":"27","author":"Santos","year":"2017","journal-title":"Neuromuscul Disord"},{"issue":"1\u20132","key":"10.1016\/j.nmd.2019.07.006_bib0028","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0165-5728(00)00250-2","article-title":"T cell recognition of muscle acetylcholine receptor in ocular myasthenia gravis","volume":"108","author":"Wang","year":"2000","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nmd.2019.07.006_bib0029","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1196\/annals.1405.037","article-title":"Extraocular muscle susceptibility to myasthenia gravis: unique immunological environment?","volume":"1132","author":"Soltys","year":"2008","journal-title":"Ann N Y Acad Sci."},{"issue":"2","key":"10.1016\/j.nmd.2019.07.006_bib0030","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.expneurol.2004.06.005","article-title":"Complement regulators in extraocular muscle and experimental autoimmune myasthenia gravis","volume":"189","author":"Kaminski","year":"2004","journal-title":"Exp Neurol"},{"issue":"3 Pt 1","key":"10.1016\/j.nmd.2019.07.006_bib0031","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1212\/WNL.45.3.516","article-title":"The gamma-subunit of the acetylcholine receptor is not expressed in the levator palpebrae superioris","volume":"45","author":"Kaminski","year":"1995","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.nmd.2019.07.006_bib0032","first-page":"345","article-title":"Expression of acetylcholine receptor isoforms at extraocular muscle endplates","volume":"37","author":"Kaminski","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.nmd.2019.07.006_bib0033","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1749-6632.2002.tb02838.x","article-title":"Extraocular muscle fatigue","volume":"956","author":"Kaminski","year":"2002","journal-title":"Ann N Y Acad Sci"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896619302573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896619302573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:08:40Z","timestamp":1760774920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896619302573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0960896619302573"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2019.07.006","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterogeneity and shifts in distribution of muscle weakness in myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2019.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}